Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Who’s Next In Congressional Hot Seat? Pharma Industry Could Replace FDA

Executive Summary

Congress will not keep up its intense scrutiny of FDA when President-elect Barack Obama takes office, drug and device lawyers predict. Instead, Capitol Hill will shift its attention to pharmaceutical company practices
Advertisement

Related Content

GSK Avodart TV Ad Cited By FDA For Out-Of-This World Efficacy Comparison
GSK Avodart TV Ad Cited By FDA For Out-Of-This World Efficacy Comparison
PhRMA’s Revised DTC Code Shies Away From Internet; Not Celebrities
PhRMA’s Revised DTC Code Shies Away From Internet; Not Celebrities
Pre-emption Rule Delays Safety-related Label Changes, Waxman Charges
Rep. Waxman Launches Salvo Against FDA Pre-emption Of State Tort Suits
Advertisement
UsernamePublicRestriction

Register

PS050489

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel